NCT00235001已完成4 期
A Multicenter, Open, Phase IV, 24-Hour Ambulatory Blood Pressure Monitoring Study of the Efficacy and Safety of Tarka in Patients With Arterial Hypertension
适应症
干预措施
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- Abbott
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- Change in blood pressure from baseline/blood pressure control
研究概览
简要总结
This study will investigate antihypertensive activity and safety profile of Tarka in Russian hypertension patients by ambulatory blood pressure measurement (ABPM)
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Hypertension
排除标准
- •SBP > 180 mm Hg, DBP > 114 mm Hg
- •Subject has a hypersensitivity to trandolapril or verapamil
研究组 & 干预措施
1
Experimental
干预措施: trandolapril/verapamil (Drug)
结局指标
主要结局
Change in blood pressure from baseline/blood pressure control
时间窗: Baseline to 3 months of Tx
次要结局
- Absolute BP reduction from baseline, safety(Baseline to 3 months of Tx)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy VolunteersIrritable Bowel SyndromeNCT03154086GlaxoSmithKline68
撤回
3 期
Pharmacokinetics, Safety, and Efficacy of Intravenous Dosing of Buprenorphine in Pediatric Patients Who Require Opioid Analgesia for Acute Moderate to Severe PainOther Acute Postoperative PainProlonged Endotracheal IntubationNCT01324544Purdue Pharma LP
已完成
3 期
Study of PlasmaCap IG in Adults and Children With PIDDPrimary Immune Deficiency Diseases (PIDD)NCT03238079Evolve Biologics63
终止
1 期
First in Human Study to Evaluate the Safety, Tolerability of HH30134 in Advanced Solid TumorsAdvanced Solid TumorsNCT04746612Haihe Biopharma Co., Ltd.22
终止
1 期
A Phase Ib Study of CT053PTSA in Relapsed / Refractory Acute Myeloid Leukemia (AML)Acute Myeloid Leukemia (AML)NCT03125876Sunshine Lake Pharma Co., Ltd.12